8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

March 6, 2003 (February 28, 2003)

AMERICAN TECHNOLOGY CORPORATION

(Exact Name of Registrant as Specified in Charter)

Delaware	0-24248	87-0361799
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1311 Evening Creek Drive South, San Diego, California (Address of Principal Executive Offices) 92128 (Zip Code)

(858) 679-2114

(Registrant’s telephone number, including area code)

Item 5.    Other Events and Regulation FD Disclosure

American Technology Corporation (the “Company”) has sold in a private offering $3,207,500 of Series E Preferred Stock, par value $.00001, at $10.00 per share (the “Series E Preferred”) to a limited number of investors (the “Series E Financing”). In connection with the Series E Financing, the Company amended its 8% Senior Secured Promissory Notes (the “Notes”) (i) to allow the holders of the Notes to convert all or a portion of the principle balance of the Notes into Series E Preferred and (ii) to extend the due date of the unconverted balance of the Notes from December 31, 2003 to December 31, 2004. The Company raised an aggregate of $2,207,500 in new cash and converted Notes with an aggregate value of $1,000,000. A total of $1,000,000 in principal amount of the Notes remains outstanding. The amendment to the Notes also clarified that Note balances converted to Series E Preferred would not be included for purposes of determining whether mandatory redemption of the remaining Note balance is required. Accordingly, mandatory redemption of the remaining Notes will not occur unless and until the Company raises at least $792,500 in additional new money from the sale of equity securities.

The purchase price of the 320,750 shares of Series E Preferred, increased by $0.60 per share of Series E Preferred per year, may be converted at the election of a Series E Preferred shareholder one or more times into fully paid and non-assessable shares of common stock, par value $.00001, of the Company at a conversion price of $3.25. If after September 30, 2003, 90% of the volume weighted average price of the Company’s common stock for the five (5) trading days prior to conversion (the “Discount Market Price”) is less than $3.25, the conversion price will be reduced to the Discount Market Price; provided, however, that the conversion price cannot be below $2.00 per share. The Series E Preferred may be called by the Company for conversion if the market price of the Company’s common stock exceeds $9.50 per shares for ten (10) consecutive trading days and certain conditions are met. The Series E Preferred will be subject to mandatory conversion on December 31, 2006.

Each purchaser of Series E Preferred was also granted a warrant (the “Warrant”) to purchase one and one half (1.5) shares of common stock for each share of Series E Preferred purchased, exercisable until December 31, 2007 at a price of $3.25 per share. In connection with the Series E Financing, the Company issued Warrants exercisable for an aggregate of 481,125 shares.

The Series E Financing resulted in a repricing of the 517,880 warrants previously issued in connection with the Company’s Series D Preferred Stock financing (the “Series D Warrants”) from $4.50 per share to $3.01 per share in accordance with repricing provisions of such warrants.

The Series E Preferred and the Warrants were offered and sold without the registration under the Securities Act of 1933, as amended (the “Act”), to a limited number of accredited investors in reliance upon the exemption provided by Rule 506 of Regulation D thereunder, and to a limited number of foreign investors in sales outside the United States in accordance with Regulation S thereunder. An appropriate legend was placed on the Series E Preferred and the Warrants and will be placed upon the shares issuable upon conversion of the Series E Preferred or upon exercise of the Warrants unless registered under the Act prior to issuance. The Company has agreed to file a registration statement covering the stock issuable upon conversion of the Series E Preferred and exercise of the Warrants on or before May 31, 2003.

Net proceeds from the Series E Financing of $2,117,500 (excluding estimated finders fees, offering costs and the value of converted Notes) are intended primarily for working capital.

2

This Current Report on Form 8-K is neither an offer to sell nor a solicitation of an offer to buy any of these securities. This Form 8-K is being filed pursuant to and in accordance with Rule 135c under the Act.

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

(a) Financial Statements of Business Acquired.

None

(b) Pro Forma Financial Information.

None

(c) Exhibits.

4.1	Form of Series E Preferred Stock and Warrant Purchase Agreement.
4.2	Certificate of Designation of Series E Preferred Stock filed with Delaware on February 28, 2003.
4.3	Form of Common Stock Warrant.
4.4	Form of 8% Senior Secured Promissory Note. Filed as Exhibit 4.1 on Form 8-K filed on October 7, 2002.
4.5	Form of Security Agreement. Filed as Exhibit 4.2 on Form 8-K filed on October 7, 2002.
4.6	Form of Amendment to 8% Senior Secured Promissory Note.

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AMERICAN TECHNOLOGY CORPORATION
Date: March 6, 2003	By:	/s/    Elwood G. Norris
		Elwood G. Norris Chairman of the Board

4

EX-4.1

EXHIBIT 4.1

AMERICAN TECHNOLOGY

CORPORATION

SERIES E PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT

                         , 2003

TABLE OF CONTENTS

			Page
1.    AGREEMENT TO SELL AND PURCHASE			1
	1.1	Authorization of Shares	1
	1.2	Sale and Purchase	1
2.    CLOSING, DELIVERY AND PAYMENT			2
	2.1	Closing	2
	2.2	Delivery	2
	2.3	Subsequent Sales of Shares	2
3.    REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY			3
	3.1	Organization, Good Standing and Qualification	3
	3.2	Subsidiaries	3
	3.3	Capitalization; Voting Rights	3
	3.4	Authorization; Binding Obligations	4
	3.5	SEC Reports and Filings.	4
	3.6	Changes	5
	3.7	Title of Properties and Assets; Liens, etc.	5
	3.8	Compliance with Other Instruments	5
	3.9	Litigation	5
	3.10	Employees	5
	3.11	Registration Rights	6
	3.12	Compliance with Laws; Permits	6
	3.13	Patents and Trademarks	6
	3.14	Offering Valid	7
	3.15	Eligibility for Form S-3	7
	3.16	Reporting Status	7
	3.17	NASDAQ SmallCap Market	7
4.    REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS			8
	4.1	Requisite Power and Authority	8
	4.2	Investment Representations	8
5.    CONDITIONS TO CLOSING			12
	5.1	Conditions to Purchasers’ Obligations at the Closing	12
	5.2	Conditions to Obligations of the Company	12
6.    REGISTRATION RIGHTS			13
	6.1	Definitions	13
	6.2	Mandatory Registration	14
	6.3	Expenses of Registration	14
	6.4	Obligations of the Company	15
	6.5	Obligations of Holder	15

i

TABLE OF CONTENTS

(continued)

			Page
	6.6	Indemnification	16
	6.7	Assignment of Registration Rights	18
7.    MISCELLANEOUS			18
	7.1	Governing Law	18
	7.2	Survival	19
	7.3	Successors and Assigns	19
	7.4	Entire Agreement	19
	7.5	Severability	19
	7.6	Amendment and Waiver	19
	7.7	Delays or Omissions	19
	7.8	Notices	20
	7.9	Expenses	20
	7.10	Attorneys' Fees	20
	7.11	Confidentiality	20
	7.12	Titles and Subtitles	20
	7.13	Counterparts	20
	7.14	Broker's Fees	20
	7.15	Exculpation Among Purchasers	20
	7.16	Pronouns	21

ii

List of Exhibits

Schedule of Purchasers	Exhibit A
Certificate of Designation	Exhibit B
Form of Warrant Agreement	Exhibit C
Request to Convert 8% Senior Secured Promissory Note	Exhibit D

iii

AMERICAN TECHNOLOGY CORPORATION

SERIES E PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT

THIS SERIES E PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (the “Agreement”) is entered into as of             , 2003, by and among American Technology Corporation, a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, whose names are set forth on the Schedule of Purchasers attached hereto as Exhibit A (which persons and entities are hereinafter collectively referred to as “Purchasers” and each individually as a “Purchaser”).

RECITALS

WHEREAS, the Company has authorized the sale and issuance of an aggregate of up to three hundred fifty thousand (350,000) shares of its Series E Preferred Stock (the “Shares”) and warrants to purchase an aggregate of up to five hundred twenty-five thousand (525,000) shares of its Common Stock (the “Warrants,” and together with the Shares, the “Securities”);

WHEREAS, Purchasers desire to purchase the Securities on the terms and conditions set forth herein; and

WHEREAS, the Company desires to issue and sell the Securities to Purchasers on the terms and conditions set forth herein.

NOW, THEREFORE, in consideration of the foregoing recitals and the mutual promises hereinafter set forth, the parties hereto agree as follows:

1.    AGREEMENT TO SELL AND PURCHASE.

1.1    Authorization of Shares.    On or prior to the Closing (as defined in Section 2 below), the Company shall have authorized (i) the sale and issuance to Purchasers of the Securities, and (ii) the issuance of such shares of Common Stock to be issued upon conversion or exercise, as the case may be, of the Securities (the “Conversion Shares”). The Shares and the Conversion Shares shall have the rights, preferences, privileges and restrictions set forth in the Company’s Certificate of Designation of Series E Preferred Stock, in the form attached hereto as Exhibit B (the “Certificate of Designation”) and in the Company’s Certificate of Incorporation, as amended (collectively with the Certificate of Designation, the “Charter”).

1.2    Sale and Purchase.    Subject to the terms and conditions hereof, at the Closing (as hereinafter defined) the Company hereby agrees to issue and sell to each Purchaser, severally and not jointly, and each Purchaser agrees to purchase from the Company, severally and not jointly, the number of Shares set forth opposite such Purchaser’s name on Exhibit A, at a purchase price of Ten Dollars ($10.00) per share and a Warrant, in the form attached hereto as Exhibit C, to purchase the number of shares of Common Stock set forth opposite such Purchaser’s name on Exhibit A.

2.    CLOSING, DELIVERY AND PAYMENT.

2.1    Closing.    The closing of the sale and purchase of the Securities under this Agreement (the “Closing”) shall take place at 10:00 a.m. on the date hereof, at the offices of Procopio, Cory, Hargreaves & Savitch LLP, 530 B Street, Suite 2100, San Diego, California 92101, or at such other time or place as the Company and Purchasers may mutually agree (such date is hereinafter referred to as the “Closing Date”).

2.2    Delivery.

(a)    Closing Deliveries.    At the Closing, each Purchaser shall pay the purchase price for the Securities as set forth next to such Purchaser’s name on Exhibit A hereto by delivering immediately available funds in United States Dollars, along with an executed Stock Purchase Agreement, to the Company’s offices. The Company shall deliver certificates for the Shares and Warrants, registered in the name of such Purchaser, to the Purchaser.

(b)    Method of Payment.    Payment of the purchase price for the Securities shall be made by conversion of all or a portion of the principle balance and any unpaid accrued interest thereon pursuant to the Company’s 8% Senior Secured Promissory Notes (the “Notes”) by written request in the form attached hereto as Exhibit D and/or by wire transfer of funds to:

US Bank

PO Box 64799

St. Paul, MN 55164

1-800-673-3555

ABA#: 122235821

Account Name: American Technology Corporation

Account#: 165600532825

2.3    Subsequent Sales of Shares.    At any time on or before the 60th day following the Closing, the Company may sell up to the balance of the authorized shares of Series E Preferred Stock and Warrants not sold at the Closing to such persons as may be approved by the Board of Directors of the Company. All such sales shall be made on the terms and conditions set forth in this Agreement, including, without limitation, the representations and warranties by such Purchasers as set forth in Section 4. Any Shares of Series E Preferred Stock sold pursuant to this Section 2.3 shall be deemed to be “Shares” for all purposes under this Agreement, any Warrants sold pursuant to this Section 2.3 shall be deemed “Warrants” for all purposes under this Agreement, and any purchasers thereof shall be deemed to be “Purchasers” for all purposes under this Agreement.

2

3.    REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY.

Except as set forth in the SEC Documents (defined in Section 3.5 below) or in the Disclosure Letter delivered to the Purchasers, the Company hereby represents and warrants to, and covenants with, each Purchaser as of the date of this Agreement as follows:

3.1    Organization, Good Standing and Qualification.    The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. The Company has all requisite corporate power and authority to own and operate its properties and assets, to execute and deliver this Agreement and the Warrants to issue and sell the Securities and the Conversion Shares and to carry out the provisions of this Agreement, the Warrants and the Charter and to carry on its business as presently conducted and as presently proposed to be conducted. The Company is duly qualified and is authorized to do business and is in good standing as a foreign corporation in all jurisdictions in which the nature of its activities and of its properties (both owned and leased) makes such qualification necessary, except for those jurisdictions in which failure to do so would not have a material adverse effect on the Company or its business.

3.2    Subsidiaries.    The Company owns no equity securities of any other corporation, limited partnership or similar entity. The Company is not a participant in any joint venture, partnership or similar arrangement.

3.3    Capitalization; Voting Rights.    The authorized capital stock of the Company consists of: (A) 50,000,000 shares of Common Stock, par value $.00001 per share, of which, as of January 31, 2003 (the “Reference Date”), (i) 14,912,899 shares are issued and outstanding, (ii) 1,419,225 shares are subject to outstanding options, (iii) 1,245,825 shares are reserved for future issuance to employees, directors and consultants pursuant to the Company’s stock option plans, (iv) 2,105,380 shares are subject to outstanding warrants, and (v) 1,173,766 shares are issuable upon conversion of outstanding convertible promissory notes; and (B) 5,000,000 shares of Preferred Stock, par value $.00001 per share, of which (i) 350,000 shares are designated Series A Preferred Stock, no shares of which are outstanding as of the Reference Date, (ii) 250,000 shares are designated Series B Preferred Stock, no shares of which are outstanding as of the Reference Date, (iii) 300,000 shares are designated as Series C Preferred Stock, 10,000 shares of which are outstanding as of the Reference Date and are convertible into 40,792 shares of Common Stock as of the Reference Date, (iv) 250,000 shares are designated Series D Preferred Stock, 85,000 of which are outstanding as of the Reference Date and (v) 350,000 shares are designated Series E Preferred Stock, none of which, prior to the Closing, are issued and outstanding. All issued and outstanding shares of the Company’s Common Stock (a) have been duly authorized and validly issued, and (b) are fully paid and nonassessable. The rights, preferences, privileges and restrictions of the Shares are as stated in the Charter. 1,076,924 shares of Common Stock have been duly and validly reserved for issuance as Conversion Shares, and the Company will take all reasonable measures to ensure that, at all times, a sufficient number of shares of its Common Stock are reserved for issuance upon conversion of the Shares and exercise of the Warrants. As of the Reference Date, other than the shares of capital stock issuable upon exercise or conversion of the foregoing outstanding options,

3

warrants, convertible promissory notes and convertible securities, and except as may be granted pursuant to this Agreement or the Warrants, there are no outstanding options, warrants, rights (including conversion, anti-dilution or preemptive rights and rights of first refusal), proxy or stockholder agreements, or agreements of any kind for the purchase or acquisition from the Company of any of its securities. When issued in compliance with the provisions of this Agreement and the Charter, the Securities and the Conversion Shares will be validly issued, fully paid and nonassessable, and will be free of any liens or encumbrances; provided, however, that the Shares and the Conversion Shares may be subject to restrictions on transfer under state and/or federal securities laws as set forth herein or as otherwise required by such laws at the time a transfer is proposed.

3.4    Authorization; Binding Obligations.    All corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization of this Agreement and the Warrants, the performance of all obligations of the Company hereunder and thereunder at the Closing and the authorization, sale, issuance and delivery of the Securities pursuant hereto and the Conversion Shares pursuant to the Charter has been taken or will be taken prior to the Closing. The Agreement, and the Warrants, when executed and delivered, will be valid and binding obligations of the Company enforceable in accordance with their terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights; (b) general principles of equity that restrict the availability of equitable remedies; and (c) to the extent that the enforceability of the indemnification provisions in Section 6.6 of this Agreement may be limited by applicable laws. The sale of the Securities and the subsequent conversion or exercise of the Securities, as the case may be, into Conversion Shares are not and will not be subject to any preemptive rights, anti-dilution or rights of first refusal that have not been properly waived or complied with.

3.5    SEC Reports and Filings.    The Company has delivered to Purchaser complete and accurate copies of (i) the Annual Report on Form 10-K for the fiscal year ended September 30, 2002, (ii) the amended Annual Report on Form 10-K for the fiscal year ended September 30, 2002, (iii) the Quarterly Report on Form 10-Q for the quarter ended December 31, 2002, and (iv) a copy of the prospectus, as supplemented (the “Prospectus”) used in the current resale offering declared effective February 6, 2003, each as filed by the Company with the Securities and Exchange Commission (“SEC”) (the “SEC Documents”). The Prospectus does not apply to the offer and sale of the Securities, and is provided for information only. The SEC Documents, including the financial statements contained therein, (i) complied with the requirements of the Securities Act of 1933, as amended (the “Securities Act”) or the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as the case may be, at and as of the times they were filed (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing) in all material respects and (ii) did not at and as of the time they were filed (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The Company has made all filings with the SEC required under the Securities Act, the Exchange Act and all regulations promulgated thereunder since January 1, 2000.

4

3.6    Changes.    Since February 7, 2003, there has been no material adverse change or disruption in the business, operations, prospects or financial condition of the Company other than as disclosed in the SEC Documents.

3.7    Title to Properties and Assets; Liens, etc.    The Company has good and marketable title to its properties and assets, including the properties and assets reflected in the most recent balance sheet included in the SEC Documents, and good title to its leasehold estates, in each case subject to no mortgage, pledge, lien, lease, encumbrance or charge, other than (a) those resulting from taxes which have not yet become delinquent, (b) a lien on the Company’s accounts receivable, equipment, goods, instruments and inventory in favor of the purchasers of the Notes, (c) minor liens and encumbrances which do not materially detract from the value of the property subject thereto or materially impair the operations of the Company, and (d) those that have otherwise arisen in the ordinary course of business. All facilities, machinery, equipment, fixtures, vehicles and other properties owned, leased or used by the Company are in good operating condition and repair and are reasonably fit and usable for the purposes for which they are being used. The Company is in compliance with all material terms of each lease to which it is a party or is otherwise bound.

3.8    Compliance with Other Instruments.    The Company is not in violation or default of any term of its Charter or bylaws, or of any provision of any mortgage, indenture, contract, agreement, instrument or contract to which it is party or by which it is bound or of any judgment, decree, order, writ or, to its knowledge, any statute, rule or regulation applicable to the Company which would materially and adversely affect the business, assets, liabilities, financial condition or operations of the Company. The execution, delivery, and performance of and compliance with this Agreement, and the Warrants, and the issuance and sale of the Securities pursuant hereto and of the Conversion Shares pursuant to the Certificate of Designations and the Charter, will not, with or without the passage of time or giving of notice, result in any such material violation, or be in conflict with or constitute a default under any such term, or result in the creation of any mortgage, pledge, lien, encumbrance or charge upon any of the properties or assets of the Company or the suspension, revocation, impairment, forfeiture or nonrenewal of any permit license, authorization or approval applicable to the Company, its business or operations or any of its assets or properties.

3.9    Litigation.    There is no action, suit, proceeding or investigation pending or to the Company’s knowledge currently threatened in writing against the Company that questions the validity of this Agreement or the Warrants or the right of the Company to enter into any of such agreements, or to consummate the transactions contemplated hereby or thereby, or which might result, either individually or in the aggregate, in any material adverse change in the assets, prospects, condition or affairs of the Company, financially or otherwise, or any change in the current equity ownership of the Company, nor is the Company aware that there is any basis for the foregoing.

3.10    Employees.    The Company has no collective bargaining agreements with any of its employees. There is no labor union organizing activity pending or, to the Company’s knowledge, threatened with respect to the Company.

5

3.11    Registration Rights.    Except as required pursuant to this Agreement and pursuant to the terms of a Series C Stock and Warrant Purchase Agreement, a Series D Stock and Warrant Purchase Agreement and an aggregate of $2,025,000 in principal amount of 12% Convertible Subordinated Promissory Notes due December 31, 2003, the Company is presently not under any obligation, and has not granted any rights, to register (as defined in Section 6.1 of this Agreement) any of the Company’s presently outstanding securities or any of its securities that may hereafter be issued.

3.12    Compliance with Laws; Permits.    To its knowledge, the Company is not in violation of any applicable statute, rule, regulation, order or restriction of any domestic or foreign government or any instrumentality or agency thereof or any administrative or self-regulatory agency in respect of the conduct of its business or the ownership of its properties which violation would materially and adversely affect the business, assets, liabilities, financial condition or operations of the Company. No orders, permissions, consents, approvals or authorizations are required to be obtained and no registrations or declarations are required to be filed in connection with the execution and delivery of this Agreement and the issuance of the Securities or the Conversion Shares, except such as has been duly and validly obtained or filed, or with respect to any filings that must be made after the Closing, as will be filed in a timely manner. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business as now being conducted by it, the lack of which could materially and adversely affect the business, properties, prospects or financial condition of the Company and believes it can obtain, without undue burden or expense, any similar authority for the conduct of its business as planned to be conducted.

3.13    Patents and Trademarks.    To the best of its knowledge, the Company owns or possesses sufficient legal rights to all patents, trademarks, service marks, trade names, copyrights, trade secrets, information and other proprietary rights and processes necessary for its business as now conducted and as proposed to be conducted, without any known infringement of the rights of others. There are no outstanding options, licenses or agreements of any kind relating to the foregoing, except those disclosed in the SEC Documents and those entered into in the ordinary course of the Company’s business. The Company has not received any communications alleging that the Company has violated or, by conducting its business as proposed, would violate any of the patents, trademarks, service marks, trade names, copyrights or trade secrets or other proprietary rights of any other person or entity. The Company is not aware that any of its employees is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would interfere with their duties to the Company or that would conflict with the Company’s business as proposed to be conducted. Neither the execution nor delivery of this Agreement, nor the carrying on of the Company’s business by the employees of the Company, nor the conduct of the Company’s business as proposed, will, to the Company’s knowledge, conflict with or result in a breach of the terms, conditions or provisions of, or constitute a default under, any contract, covenant or instrument under which any employee is now obligated. The Company does not believe it is or will be necessary to utilize any inventions, trade secrets or proprietary information of any of its employees made prior to their employment by the Company, except for inventions, trade secrets or proprietary information that have been assigned to the Company.

6

3.14    Offering Valid.    Assuming the accuracy of the representations and warranties of the Purchasers contained in Section 4.2 hereof, the offer, sale and issuance of the Securities and the Conversion Shares will be exempt from the registration requirements of the Securities Act and will have been registered or qualified (or are exempt from registration and qualification) under the registration, permit or qualification requirements of all applicable state securities laws. Neither the Company nor any agent on its behalf has solicited or will solicit any offers to sell or has offered to sell or will offer to sell all or any part of the Securities to any person or persons so as to bring the sale of such Securities by the Company within the registration provisions of the Securities Act or any state securities laws.

3.15    Eligibility for Form S-3.    The Company represents and warrants that it meets the requirements for the use of Form S-3 for registration of the sale by the Purchaser of the Conversion Shares, and the Company shall file all reports required to be filed by the Company with the SEC in a timely manner and take all other necessary action so as to maintain such eligibility for the use of Form S-3.

3.16    Reporting Status.    The Company’s Common Stock is registered under Section 12 of the Exchange Act. So long as any Purchaser beneficially owns any of the Securities or Conversion Shares, the Company shall timely file all reports required to be filed with the SEC pursuant to the Exchange Act, and the Company shall not voluntarily terminate its status as an issuer required to file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would permit such termination.

3.17    NASDAQ SmallCap Market.    The Company’s Common Stock is listed on the Nasdaq SmallCap Market maintained by the National Association of Securities Dealers, Inc. (“NASD”), and for so long as any Purchaser owns any of the Securities or Conversion Shares, the Company shall use its best efforts to continue the listing and trading of its Common Stock on the Nasdaq SmallCap Market or to secure and maintain listing and trading on the Nasdaq National Market System, the New York Stock Exchange or the American Stock Exchange, and shall comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of such market or exchange. The Company is not aware of any delisting or suspension proceeding regarding its Common Stock or any SEC or NASD inquiries regarding the Company and does not reasonably anticipate any such delisting, suspension or inquiry.

7

4.    REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS.

Each Purchaser hereby represents and warrants, severally and not jointly, to the Company as follows:

4.1    Requisite Power and Authority.    Purchaser has all necessary power and authority under all applicable provisions of law to execute and deliver this Agreement and the Warrants and to carry out their provisions. All action on Purchaser’s part required for the lawful execution and delivery of this Agreement and the Warrants has been or will be effectively taken prior to the Closing. Upon its execution and delivery, this Agreement and the Warrants will be a valid and binding obligation of Purchaser, enforceable in accordance with its terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights, (b) general principles of equity that restrict the availability of equitable remedies, and (c) to the extent that the enforceability of the indemnification provisions of Section 6.6 of this Agreement may be limited by applicable laws.

4.2    Investment Representations.    Purchaser understands that neither the Securities nor the Conversion Shares have been registered under the Securities Act, and that the certificates representing the Shares and the Conversion Shares will contain appropriate restrictive legends. Purchaser also understands that the Securities are being offered and sold pursuant to an exemption from registration contained in the Securities Act based in part upon Purchaser’s representations contained in the Agreement. Purchaser hereby represents and warrants as follows:

(a)    Purchaser Bears Economic Risk.    Purchaser has substantial experience in evaluating and investing in private placement transactions of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company and has the capacity to protect its own interests. Purchaser must bear the economic risk of this investment indefinitely unless the Securities (or the Conversion Shares) are registered pursuant to the Securities Act, or an exemption from registration is available. Purchaser understands that other than pursuant to the terms of this Agreement, the Company has no present intention of registering the Securities or the Conversion Shares. Purchaser also understands that there is no assurance that any exemption from registration under the Securities Act will be available and that, even if available, such exemption may not allow Purchaser to transfer all or any portion of the Securities or the Conversion Shares under the circumstances, in the amounts or at the times Purchaser might propose.

(b)    Acquisition for Own Account.    Purchaser is acquiring the Securities and the Conversion Shares for Purchaser’s own account for investment only, and not with a present view towards their distribution other than in compliance with the Securities Act.

(c)    Purchaser Can Protect Its Interest.    Purchaser represents that by reason of its, or of its management’s, business or financial experience, Purchaser has the capacity to protect its own interests in connection with the transactions contemplated in this Agreement. Further, Purchaser is aware of no publication of any advertisement in connection with the transactions contemplated in the Agreement.

8

(d)    Accredited Investor.    Unless Purchaser has initialed the blank next to Section 4.2(h) below, Purchaser represents that it is an accredited investor within the meaning of Regulation D under the Securities Act.

(e)    Company Information.    Purchaser has received and read the SEC Documents and has had an opportunity to discuss the Company’s business, management and financial affairs with directors, officers and management of the Company and has had the opportunity to review the Company’s operations and facilities. Purchaser has also had the opportunity to ask questions of and receive answers from, the Company and its management regarding the terms and conditions of this investment.

(f)    Rule 144.    Purchaser acknowledges and agrees that the Securities, and, if issued, the Conversion Shares must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Purchaser has been advised or is aware of the provisions of Rule 144 promulgated under the Securities Act as in effect from time to time, which permits limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions, including, among other things: the availability of certain current public information about the Company, the resale occurring following the required holding period under Rule 144 and (other than Rule 144(k)) the number of shares being sold during any three-month period not exceeding specified limitations.

(g)    Residence.    If the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth on Exhibit A; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office or offices of the Purchaser in which its investment decision was made is located at the address or addresses of the Purchaser set forth on Exhibit A.

(Initial if applicable)             

(h)    Foreign Investors.    Regulation S Representations.    The representations in this Section 4.2(h) apply only to Purchasers who enter their initials next to this section. Purchaser understands that the Company is relying on the following representations and warranties, and other representations and warranties in the Section 4, for the purpose of establishing that the offer and sale of the Securities is excluded from Section 5 of the Securities Act by virtue of Regulation S.

i.    All offers and sales of securities to Purchaser were made in an offshore transaction, as defined in Rule 902(h) of Regulation S. Specifically, the offer to sell the Securities was made to Purchaser who was located outside the United States at the time of such offer, and this Agreement was executed by Purchaser or a duly authorized representative of Purchaser located outside the United States at the time of execution.

ii.    If Purchaser attempts to sell, transfer or otherwise dispose of the Securities or the Conversion Shares prior to one year after the Closing, such Purchaser agrees that:

a.    Each “Distributor” (as defined in Regulation S, Rule 902(d)) in connection with such resale agrees in writing (i) that all offers and sales of the

9

Securities and the Conversion Shares prior to the expiration of the Distribution Compliance Period (as defined in Regulation S, Rule 902(f)) shall be made only in accordance with the provisions of Regulation S, Rule 903 or Rule 904, pursuant to registration of such securities under the Securities Act, or pursuant to an available exemption from the registration requirements of the Securities Act; and (ii) not to engage in hedging transactions with regard to such securities prior to the expiration of the Distribution Compliance Period, unless in compliance with the Securities Act.

b.    All offering materials and documents (other than press releases) used in connection with offers and sales of the Securities and the Conversion Shares prior to the expiration of the Distribution Compliance Period shall include statements to the effect that such securities have not been registered under the Securities Act and may not be offered or sold in the United States or to U.S. Persons (as defined in Section 4.2(h)(iii)), other than Distributors, unless the securities are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available. Such offering materials and documents also must state that hedging transactions involving those securities may not be conducted unless in compliance with the Securities Act. Such statements shall appear (i) on the cover or inside cover page of any prospectus or offering circular used in connection with the offer or sale of the securities; (ii) in the underwriting section of any prospectus or offering circular used in connection with the offer or sale of the securities; and (iii) in any advertisement made or issued by the Company, any Distributor, any of their respective affiliates, or any person acting on behalf of any of the foregoing. Such statements may appear in summary form on prospectus cover pages and in advertisements.

c.    The offer or sale of the Securities and the Conversion Shares by such Purchaser shall not be made to a U.S. Person or for the account of a U.S. Person, other than a Distributor.

d.    The offer and sale of the Securities and the Conversion Shares shall also comply with the following conditions (i) such Purchaser shall require that prior to the sale or transfer, the purchaser of the Securities or the Conversion Shares (other than a Distributor) certifies that it is not a U.S. Person and is not acquiring such securities for the account or benefit of any U.S. Person or certifies that it is a U.S. Person who purchased securities in a transaction that did not require registration under the Securities Act; (ii) such Purchaser shall require that prior to the sale or transfer, the purchaser of such securities agrees to resell such securities only in accordance with the provisions of Regulation S, pursuant to registration under the Securities Act, or pursuant to an available exemption from registration; and agrees not to engage in hedging transactions with regard to such securities unless in compliance with the Securities Act; (iii) such Purchaser shall require each Distributor selling securities to a Distributor, a dealer (as defined in Section 2(12) of the Securities Act), or a person receiving a selling concession, fee or other remuneration, prior to the expiration of the Distribution Compliance Period, to send a confirmation or other notice to the purchaser stating that the purchaser is subject to the same restrictions on offers and sales that apply to the Distributor.

e.    Such Purchaser understands that the Securities and the Conversion Shares will at all times, prior to the expiration of the Distribution Compliance

10

Period, contain a legend to the effect that transfer is prohibited except in accordance with the provisions of Regulation S, pursuant to registration under the Securities Act, or pursuant to an available exemption from registration; and that hedging transactions involving these securities may not be conducted unless in compliance with the Securities Act.

f.    Such Purchaser further understands the Company, to comply with Regulation S, shall refuse to register any transfer of the Securities or the Conversion Shares not made in accordance with the provisions of Regulation S, pursuant to registration under the Securities Act, or pursuant to an available exemption from registration.

iii.    Such Purchaser is not a U.S. Person and is not acquiring the Securities for the account or benefit of any U.S. Person. The term “U.S. Person” means (i) any natural person resident in the United States; (ii) any partnership or corporation organized or incorporated under the laws of the United States; (iii) any estate of which any executor or administrator is a U.S. Person; (iv) any trust of which any trustee is a U.S. Person; (v) any agency or branch of a foreign entity located in the United States; (vi) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. Person; (vii) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (viii) any partnership or corporation if: (1) organized or incorporated under the laws of any foreign jurisdiction; and (2) formed by a U.S. Person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a) under the Securities Act) who are not natural persons, estates or trusts. Notwithstanding the foregoing definition of “U.S. Person”: (a) any discretionary account or similar account (other than an estate or trust) held for the benefit or account of a non-U.S. Person by a dealer or other professional fiduciary organized, incorporated, or (if an individual) resident in the United States shall not be deemed a U.S. Person; (b) any estate of which any professional fiduciary acting as executor or administrator is a U.S. Person shall not be deemed a U.S. Person if: (1) an executor or administrator of the estate who is not a U.S. Person has sole or shared investment discretion with respect to the assets of the estate; and (2) the estate is governed by foreign law; (c) any trust of which any professional fiduciary acting as trustee is a U.S. Person shall not be deemed a U.S. Person if a trustee who is not a U.S. Person has sole or shared investment discretion with respect to the trust assets, and no beneficiary of the trust (and no settlor if the trust is revocable) is a U.S. Person; (d) an employee benefit plan established and administered in accordance with the law of a country other than the United States and customary practices and documentation of such country shall not be deemed a U.S. Person; (e) any agency or branch of a U.S. Person located outside the United States shall not be deemed a U.S. Person if: (1) the agency or branch operates for valid business reasons; and (2) the agency or branch is engaged in the business of insurance or banking and is subject to substantive insurance or banking regulation, respectively, in the jurisdiction where located; (f) the International Monetary Fund, the International Bank for Reconstruction and Development, the Inter-American Development Bank, the Asian Development Bank, the African Development Bank, the United Nations, and their agencies, affiliates and pension plans, and any other similar international organizations, their agencies, affiliates and pension plans shall not be deemed U.S. Persons.

11

5.    CONDITIONS TO CLOSING.

5.1    Conditions to Purchasers’ Obligations at the Closing.    Purchasers’ obligations to purchase the Securities at the Closing are subject to the satisfaction, at or prior to the Closing Date, of the following conditions:

(a)    Representations and Warranties True; Performance of Obligations.    The representations and warranties made by the Company in Section 3 hereof shall be true and correct in all material respects as of the Closing Date with the same force and effect as if they had been made as of the Closing Date, and the Company shall have performed all obligations and conditions herein required to be performed or observed by it on or prior to the Closing.

(b)    Legal Investment.    On the Closing Date, the sale and issuance of the Securities and the proposed issuance of the Conversion Shares shall be legally permitted by all laws and regulations to which Purchasers and the Company are subject.

(c)    Consents, Permits, and Waivers.    The Company shall have obtained any and all consents, permits and waivers necessary or appropriate for consummation of the transactions contemplated by the Agreement (except for such as may be properly obtained subsequent to the Closing).

(d)    Filing of Certificate of Designation.    The Certificate of Designation shall have been filed with the Secretary of State of the State of Delaware.

(e)    Reservation of Conversion Shares.    The Conversion Shares issuable upon conversion of the Shares and exercise of the Warrants shall have been duly authorized and reserved for issuance upon such conversion or exercise.

(f)    NASDAQ SmallCap Market.    The Company’s Common Stock shall be currently trading on the Nasdaq SmallCap Market. The Company and Purchasers shall not be aware of any delisting or suspension proceeding regarding the Company’s Common Stock or any SEC or NASD inquiries regarding the Company, nor shall the Company or any Purchaser reasonably anticipate any such delisting, suspension or inquiry.

(g)    Size of Offering.    Purchasers purchasing at least an aggregate of $1,000,000 of the Securities pursuant to this Agreement (including conversion of Notes) shall have purchased, or will be purchasing, such Securities prior to or concurrent with the Closing.

5.2    Conditions to Obligations of the Company.    The Company’s obligation to issue and sell the Securities at the Closing is subject to the satisfaction, on or prior to such Closing, of the following conditions:

(a)    Representations and Warranties True.    The representations and warranties made in Section 4 hereof by those Purchasers acquiring Securities shall be true and correct in all material respects at the date of the Closing, with the same force and effect as if they had been made on and as of said date.

12

(b)    Performance of Obligations.    Such Purchasers shall have performed and complied with all agreements and conditions herein required to be performed or complied with by such Purchasers on or before the Closing.

(c)    Filing of Certificate of Designation.    The Certificate of Designation shall have been filed with the Secretary of State of the State of Delaware.

(d)    Consents, Permits, and Waivers.    The Company shall have obtained any and all consents, permits and waivers necessary or appropriate for consummation of the transactions contemplated by the Agreement (except for such as may be properly obtained subsequent to the Closing).

(e)    Payment.    Each Purchaser shall have delivered to the Company either immediately available funds and/or a written request in the form of Exhibit D attached hereto to convert all or a portion of the principle balance and any unpaid accrued interest thereon pursuant to the Notes as payment in full of an amount equal to the purchase price of the Securities as set forth next to such Purchaser’s name on Exhibit A hereto in accordance with Section 2.2 hereof.

6.    REGISTRATION RIGHTS.

6.1    Definitions.    As used in this Section 6, the following terms shall have the following respective meanings:

“Form S-3” means such form under the Securities Act as in effect on the date hereof or any successor registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC.

“Holder” means any person owning of record Registrable Securities that have not been sold to the public or any assignee of record of such Registrable Securities in accordance with Section 6.7 hereof.

“Register,” “registered,” and “registration” refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or document.

“Registrable Securities” means (a) Common Stock of the Company issued or issuable upon conversion of the Shares; (b) Common Stock of the Company issued or issuable upon exercise of the Warrants; and (c) any Common Stock of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, such above-described securities. Notwithstanding the foregoing, Registrable Securities shall not include (i) any securities held by a registered broker-dealer, or any securities held by an affiliate or associate of a broker-dealer who (x) did not purchase the securities in the ordinary course of business or personal affairs or (y) at the time of purchase of the securities, had an agreement or understanding, directly or indirectly, with any person to distribute such securities, and (ii) any

13

securities sold by a person to the public either pursuant to a registration statement or Rule 144 or sold in a private transaction in which the transferor’s rights under this Section 6 are not assigned.

“Registrable Securities then outstanding” shall be the number of shares determined by calculating the total number of shares of the Company’s Common Stock that are Registrable Securities and either (a) are then issued and outstanding or (b) are issuable pursuant to then exercisable or convertible securities.

“Registration Expenses” shall mean all expenses incurred by the Company in complying with this Section 6 hereof, including, without limitation, all registration and filing fees, printing expenses, fees and disbursements of counsel for the Company, blue sky fees and expenses and the expense of any special audits incident to or required by any such registration (but excluding the compensation of regular employees of the Company which shall be paid in any event by the Company).

“SEC” or “Commission” means the Securities and Exchange Commission.

“Selling Expenses” shall mean all underwriting discounts and selling commissions applicable to the sale.

6.2    Mandatory Registration.    The Company shall prepare and file with the SEC on or before May 31, 2003 (the “SEC Filing Date”) a Registration Statement on Form S-3 or, if Form S-3 is not available, on another appropriate form reasonably acceptable to the Purchasers, which covers the resale of a number of shares of Common Stock equal to at least the number of Registrable Securities issuable to each Holder upon conversion of the Shares and exercise of the Warrants, determined as if the Shares were converted in full (based on a $3.25 per share conversion price) and the Warrants were exercised in full. If at any time the number of shares of Common Stock included in the Registration Statement required to be filed as provided in the first sentence of this Section 6.2(a) shall be insufficient to cover the number of shares of Common Stock issuable on conversion in full of the unconverted Shares and unexercised Warrants, then promptly, but in no event later than 60 days after such insufficiency shall occur, the Company shall file with the SEC an additional Registration Statement on Form S-3, or another appropriate form (which shall not constitute a post-effective amendment to the Registration Statement filed pursuant to the first sentence of this Section 6.2(a)) covering such number of shares of Common Stock as shall be sufficient to permit such conversion and exercise. For all purposes of this Agreement such additional Registration Statement shall be deemed to be the Registration Statement required to be filed by the Company pursuant to this Section 6.2(a), and the Company and the Holders shall have the same rights and obligations with respect to such additional Registration Statement as they shall have with respect to the initial Registration Statement required to be filed by the Company pursuant to this Section 6.2(a).

6.3    Expenses of Registration.    Except as specifically provided herein, all Registration Expenses incurred in connection with any registration, qualification or compliance pursuant to Section 6.2 shall be borne by the Company. All Selling Expenses incurred in connection with any registrations hereunder, shall be borne by the holders of the securities so registered pro rata on the basis of the number of shares so registered.

14

6.4    Obligations of the Company.    Whenever required to effect the registration of any Registrable Securities, the Company shall:

(a)    Prepare and file with the SEC a Registration Statement on Form S-3 with respect to the number of Registrable Securities provided in Section 6.2(a), and thereafter to use all reasonable efforts to cause each Registration Statement relating to Registrable Securities to become effective and keep the Registration Statement effective for two years after the Closing Date.

(b)    Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement for the period set forth in paragraph (a) above.

(c)    Furnish to the Holders such number of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them.

(d)    Use its reasonable best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions.

(e)    Notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, and use its best efforts to prepare a supplement or amendment to the Registration Statement to correct such untrue statement or omission, and deliver such number of copies of such supplement or amendment to each Holder as such Holder may reasonably request.

(f)    Use all reasonable efforts to prevent the issuance of stop orders or any other suspensions in trading of the Company’s Common Stock by the SEC or any applicable exchange or market, and use its best efforts to have removed or reversed any such stop order or suspension in trading that occurs.

6.5    Obligations of Holder.

(a)    No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 6.

15

(b)    It shall be a condition precedent to the obligations of the Company to take any action pursuant to Section 6.2 or 6.4 that each Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it as shall be reasonably required to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably request.

(c)    Each Holder by such Holder’s acceptance of the Registrable Securities agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of the Registration Statement hereunder, unless such Holder has notified the Company in writing of such Holder’s election to waive all of such Holder’s rights to register any securities under this Section 6;

(d)    Each Holder agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 6.4(e), such Holder will immediately discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities and all other transactions involving or relating to the Company’s securities until such Holder’s receipt of copies of a supplemented or amended prospectus and, if so directed by the Company, such Holder shall deliver to the Company (at the expense of the Company) or destroy (and deliver to the Company a certificate of destruction) all copies in such Holder’s possession, of the prospectus covering such Registrable Securities current at the time of receipt of such notice.

6.6    Indemnification.    In the event any Registrable Securities are included in a registration statement under this Section 6:

(a)    To the extent permitted by law, the Company will indemnify and hold harmless each Holder, any partner, officer or director of each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”) by the Company: (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law in connection with the offering covered by such registration statement; and the Company will pay as incurred to each such Holder, partner, officer, director, underwriter or controlling person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided however, that the indemnity agreement contained in this Section 6.6 shall not apply to amounts paid in settlement of any such loss, claim, damage,

16

liability or action if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by such Holder, partner, officer, director, underwriter or controlling person of such Holder.

(b)    To the extent permitted by law, each Holder will, if Registrable Securities held by such Holder are included in the securities as to which such registration qualifications or compliance is being effected, indemnify and hold harmless the Company, each of its directors, its officers and each person, if any, who controls the Company within the meaning of the Securities Act, any underwriter and any other Holder selling securities under such registration statement or any of such other Holder’s partners, directors or officers or any person who controls such Holder, against any losses, claims, damages or liabilities (joint or several) to which the Company or any such director, officer, controlling person, underwriter or other such Holder, or partner, director, officer or controlling person of such other Holder may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder under an instrument duly executed by such Holder and stated to be specifically for use in connection with such registration; and each such Holder will pay as incurred any legal or other expenses reasonably incurred by the Company or any such director, officer, controlling person, underwriter or other Holder, or partner, officer, director or controlling person of such other Holder in connection with investigating or defending any such loss, claim, damage, liability or action if it is judicially determined that there was such a Violation; provided, however, that the indemnity agreement contained in this Section 6.6 shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; provided further, that in no event shall any indemnity under this Section 6.6 exceed the proceeds from the offering received by such Holder.

(c)    Promptly after receipt by an indemnified party under this Section 6.6 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 6.6, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party shall have the right to retain its own counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if materially prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to the indemnified

17

party under this Section 6.6, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 6.6.

(d)    If the indemnification provided for in this Section 6.6 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any losses, claims, damages or liabilities referred to herein, the indemnifying party, in lieu of indemnifying such indemnified party thereunder, shall to the extent permitted by applicable law contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the Violation(s) that resulted in such loss, claim, damage or liability, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by a court of law by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, that in no event shall any contribution by a Holder hereunder exceed the proceeds from the offering received by such Holder.

(e)    The obligations of the Company and Holders under this Section 6.6 shall survive completion of any offering of Registrable Securities in a registration statement and the termination of this agreement. No indemnifying party, in the defense of any such claim or litigation, shall, except with the consent of each indemnified party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

6.7    Assignment of Registration Rights.    The rights to cause the Company to register Registrable Securities pursuant to this Section 6 may be assigned by a Holder to a transferee or assignee of Registrable Securities which (a) is a subsidiary, parent, general partner, limited partner, retired partner, member or retired member of a Holder, (b) is a Holder’s family member or trust for the benefit of an individual Holder, or (c) acquires at least fifty thousand (50,000) shares of Registrable Securities (as adjusted for stock splits and combinations); provided, however, (i) the transferor shall, within ten (10) days after such transfer, furnish to the Company written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned and (ii) such transferee shall agree to be subject to all restrictions set forth in this Agreement.

7.    MISCELLANEOUS.

7.1    Governing Law.    This Agreement shall be governed in all respects by the laws of the State of California as such laws are applied to agreements between California residents entered into and performed entirely in California.

18

7.2    Survival.    The representations, warranties, covenants and agreements made herein shall survive any investigation made by any Purchaser and the closing of the transactions contemplated hereby. All statements as to factual matters contained in any certificate or other instrument delivered by or on behalf of the Company pursuant hereto in connection with the transactions contemplated hereby shall be deemed to be representations and warranties by the Company hereunder solely as of the date of such certificate or instrument.

7.3    Successors and Assigns.    Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto and shall inure to the benefit of and be enforceable by each person who shall be a holder of the Securities from time to time.

7.4    Entire Agreement.    This Agreement, the Exhibits and Schedules hereto, the Warrants and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof and no party shall be liable or bound to any other in any manner by any representations, warranties, covenants and agreements except as specifically set forth herein and therein.

7.5    Severability.    In case any provision of the Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

7.6    Amendment and Waiver.

(a)    This Agreement may be amended or modified only upon the written consent of the Company and holders of at least fifty percent (50%) of the Securities (treated as if converted and including any Conversion Shares into which the Shares or Warrants have been converted or exercised that have not been sold to the public).

(b)    The obligations of the Company and the rights of the holders of the Shares, the Warrants and the Conversion Shares under this Agreement may be waived only with the written consent of the holders of at least fifty percent (50%) of the Securities (treated as if converted and including any Conversion Shares into which the Shares or Warrants have been converted or exercised that have not been sold to the public).

7.7    Delays or Omissions.    It is agreed that no delay or omission to exercise any right, power or remedy accruing to any party, upon any breach, default or noncompliance by another party under this Agreement or the Charter, shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character on any Purchaser’s part of any breach, default or noncompliance under this Agreement or under the Charter or any waiver on such party’s part of any provisions or conditions of the Agreement or the Charter must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement, the Charter, by law, or otherwise afforded to any party, shall be cumulative and not alternative.

19

7.8    Notices.    All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified; (b) when sent by confirmed facsimile if sent during normal business hours of the recipient, if not, then on the next business day; (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at the address as set forth on the signature page hereof and to Purchaser at the address set forth on Exhibit A attached hereto or at such other address as the Company or Purchaser may designate by ten (10) days advance written notice to the other parties hereto.

7.9    Expenses.    Each party shall pay all costs and expenses that it incurs with respect to the negotiation, execution, delivery and performance of this Agreement and the Warrants.

7.10    Attorneys’ Fees.    In the event that any dispute among the parties to this Agreement should result in litigation, the prevailing party in such dispute shall be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of such prevailing party under or with respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys and accountants, which shall include, without limitation, all fees, costs and expenses of appeals.

7.11    Confidentiality.    The Company shall not publicly disclose the name or identity of any Purchaser unless (i) required by law or the rules and regulations of the SEC, (ii) such Purchaser has given its prior written consent or (iii) such information is already in the public domain.

7.12    Titles and Subtitles.    The titles of the sections and subsections of the Agreement are for convenience of reference only and are not to be considered in construing this Agreement.

7.13    Counterparts.    This Agreement may be executed in any number of counterparts, by facsimile, or both, each of which shall be an original, but all of which together shall constitute one instrument.

7.14    Broker’s Fees.    Each party hereto represents and warrants that no agent, broker, investment banker, person or firm acting on behalf of or under the authority of such party hereto is or will be entitled to any broker’s or finder’s fee or any other commission directly or indirectly in connection with the transactions contemplated herein. Notwithstanding the foregoing, the Company may pay finder’s fees in cash equal to up to 5% of the purchase price of the Securities for the introduction of qualified Purchasers accepted by the Company. Each party hereto further agrees to indemnify each other party for any claims, losses or expenses incurred by such other party as a result of the representation in this Section 7.14 being untrue.

7.15    Exculpation Among Purchasers.    Each Purchaser acknowledges that it is not relying upon any person, firm, or corporation, other than the Company and its officers and

20

directors, in making its investment or decision to invest in the Company. Each Purchaser agrees that no Purchaser nor the respective controlling persons, officers, directors, partners, agents, or employees of any Purchaser shall be liable for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the Securities and Conversion Shares.

7.16    Pronouns.    All pronouns contained herein, and any variations thereof, shall be deemed to refer to the masculine, feminine or neutral, singular or plural, as to the identity of the parties hereto may require.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

21

IN WITNESS WHEREOF, the parties hereto have executed the Series E Preferred Stock and Warrant Purchase Agreement as of the date set forth in the first paragraph hereof.

Company:	Purchaser:
AMERICAN TECHNOLOGY CORPORATION	[Print Name of Purchaser]
13114 Evening Creek Drive South San Diego, California 92128
By:	By:
Name:	Title (if any)
Title:
	Street address (not PO BOX):
	Phone number:
	Fax number:
	E-mail address:

AMERICAN TECHNOLOGY CORPORATION

SIGNATURE PAGE

TO SERIES E PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT

SERIES E PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT

EXHIBIT A

SCHEDULE OF PURCHASERS

Name And Address	Aggregate Purchase Price	Number of Shares	Shares of Common Stock Underlying Warrant
[Purchaser]	$
Totals:

EXHIBIT B

CERTIFICATE OF DESIGNATION

OF

SERIES E PREFERRED STOCK

EXHIBIT C

FORM OF WARRANT AGREEMENT

EXHIBIT D

INSTRUCTIONS TO CONVERT

8% SENIOR SECURED PROMISSORY NOTE

Date:                     , 2003

American Technology Corporation

13114 Evening Creek Drive South

San Diego, California 92128

Attn: Chief Executive Officer

Ladies and Gentlemen:

The undersigned hereby requests to convert $             in principal amount (the “Redemption Principal”) of 8% Senior Secured Promissory Notes issued by American Technology Corporation (the “Company”) and due December 31, 2003, as amended             , 2003 (the “Notes”), to shares of the Company’s Series E Preferred Stock and associated warrants (the “Securities”) to be sold under the Series E Preferred Stock and Warrant Purchase Agreement dated                          , 2003 (the “Purchase Agreement”). Upon acceptance of this request by the Company, the conversion of the Redemption Principal shall be treated as a Voluntary Conversion pursuant to Section 1 of the Amendment to 8% Senior Secured Promissory Note dated             , 2003 (the “Amendment”), with accrued and unpaid interest on the Redemption Principal and the Early Retirement Premium (as defined in the Notes) paid as elected by the Company below.

Very truly yours,

Signature

Name:                                                                                            

Title:                                                                                              

[AGREEMENT AND ACCEPTANCE FOLLOWS ON NEXT PAGE]

AGREED AND ACCEPTED, WITH THE FOLLOWING INTEREST CONVERSION OPTION:

Accrued and unpaid interest on the Redemption Principal, and the Early Retirement Premium, to be paid in cash on the Redemption Date.

Accrued and unpaid interest on the Redemption Principal, and the Early Retirement Premium, to be paid applied toward the purchase price for the Securities.

A total of $             in accrued and unpaid interest on the Redemption Principal, and in Early Retirement Premium, to be paid applied toward the purchase price for the Securities, and the balance to be paid in cash on the Redemption Date.

AMERICAN TECHNOLOGY CORPORATION

By:                                                                                                  

Name:                                                                                            

Title:                                                                                              

EX-4.2

Exhibit 4.2

CERTIFICATE OF DESIGNATION

OF

SERIES E PREFERRED STOCK

OF

AMERICAN TECHNOLOGY CORPORATION,

a Delaware Corporation

PURSUANT TO SECTION 151 OF THE

GENERAL CORPORATION LAW OF THE STATE OF DELAWARE

AMERICAN TECHNOLOGY CORPORATION, a Delaware corporation (the “Corporation” or the “Company”), does hereby certify that:

I. The name of the corporation is American Technology Corporation.

II. The Company certifies that pursuant to the authority contained in its Certificate of Incorporation (the “Certificate of Incorporation”) and in accordance with the provisions of Section 151 of the General Corporation Law of the State of Delaware, the Board of Directors of the Company adopted the following resolution, which resolution remains in full force and effect on the date hereof:

RESOLVED, that there is hereby established a series of authorized preferred stock having a par value of $.00001 per share, which series shall be designated as “Series E Preferred Stock,” shall consist of 350,000 shares and shall have the following voting powers, preferences and relative, participating, optional and other special rights, and qualifications, limitations and restrictions thereof as follows:

1.    Designation and Amount.    The designation of the series of Preferred Stock shall be “Series E Preferred Stock,” par value $.00001 per share (the “Series E Preferred Stock”). The number of authorized shares of Series E Preferred Stock shall be 350,000. The Series E Preferred Stock shall have an initial issue price of Ten Dollars ($10.00) per share (the “Original Issue Price”). The date on which any shares of Series E Preferred Stock are first issued is referred to herein as the “Original Issue Date.”

2.    Dividends.    The holders of record of shares of Series E Preferred Stock shall be entitled to receive when, as and if a cash dividend on the Company’s common stock, par value $.00001 per share (the “Common Stock”), or any Junior Stock (as defined below), is declared by the Board of Directors in any year, out of funds legally available therefor, a cash dividend at a

rate per share of Series E Preferred Stock equal to six percent (6%) of the Conversion Value (as defined in 3(a) hereof) per annum, payable in preference and priority to any payment of any dividend on Common Stock of the Company, or any Junior Stock, for such year.

3.    Liquidation.

(a)    Preference Upon Liquidation, Dissolution or Winding Up.    In the event of any liquidation, dissolution or winding up of the affairs of the Company (any or all of such events, a “liquidation”), whether voluntary or involuntary, subject to the prior preferences and other rights of any Senior Stock (as defined below), if any, the holders of shares of Series E Preferred Stock then outstanding shall be entitled pari passu as if members of a single class of securities with the holders of any Parity Stock (as defined below), if any, to be paid out of the assets of the Company before any payment shall be made to the holders of Junior Stock (as defined below) an amount per share equal to the Conversion Value (as defined in Section 5(a) below), plus any declared but unpaid dividends (the “Liquidation Amount”). Except as provided in this Section 3(a), holders of Series E Preferred Stock shall not be entitled to any distribution in the event of liquidation, dissolution or winding up of the affairs of the Company. The term “Junior Stock” shall mean Common Stock or any other class or series of stock ranking junior to the Series E Preferred Stock in respect of the right to receive dividends or the right to participate in any distribution upon liquidation, the term “Senior Stock” shall mean the Company’s Series C Preferred Stock and any other class or series of stock of the Company authorized before the date of issuance of the Series E Preferred Stock, other than the Company’s Series D Preferred Stock, ranking senior to the Series E Preferred Stock in respect of the right to receive dividends or the right to participate in any distribution upon liquidation, and the term “Parity Stock” shall mean the Company’s Series D Preferred Stock and any class or series of stock of the Company authorized after the date of issuance of the Series E Preferred Stock ranking on a parity with the Series E Preferred Stock in respect of the right to receive dividends or the right to participate in any distribution upon liquidation.

(b)    Merger or Sale of Assets.    A merger of the Company in which holders of more than 50% of the outstanding Common Stock of the Company before the merger do not hold more than 50% of the outstanding Common Stock of the Company after the merger, or a sale of all or substantially all of the Company’s assets, shall be deemed to be a liquidation for purposes of this Section 3; provided, however, that a merger, consolidation or reorganization where the Company is the surviving entity, or a merger of the Company into a wholly-owned subsidiary shall not be deemed a liquidation.

(c)    Insufficient Assets.    If, upon any liquidation of the Company, the assets of the Company, after payment to the Holders of the Senior Stock, are insufficient to pay the holders of shares of the Series E Preferred Stock and any Parity Stock, if any, then outstanding the full preferential amounts to which they shall be entitled, such assets shall be distributed to each holder of the Series E Preferred Stock and Parity Stock, if any, pro rata based on the number of shares of Common Stock into which the Series E Preferred Stock and Parity Stock, if any, held by each is convertible.

2

(d)    Rights of Other Holders.    In the event of any liquidation, after payment shall have been made to the holders of the Senior Stock, the Series E Preferred Stock and Parity Stock, if any, of all preferential amounts to which they shall be entitled, the holders of shares of Junior Stock and other capital stock of the Company shall receive such amounts as to which they are entitled by the terms thereof.

4.    Voting Rights.

(a)    Voting.    Each holder of shares of Series E Preferred Stock shall be entitled to one (1) vote for each share of Series E Preferred Stock held on any matter submitted to the Company’s stockholders for their approval or consent. Except as otherwise required by law or expressly provided herein, the holders of the Series E Preferred Stock shall vote equally with the shares of Common Stock of the Company and not as a separate class on any matter to voted upon by the stockholders of the Company.

(b)    Certificate of Incorporation; Certain Stock.    The affirmative vote or consent of the holders of a majority of the outstanding shares of Series E Preferred Stock, voting separately as a class, will be required for (i) any amendment, alteration, or repeal, whether by merger or consolidation or otherwise, of the Company’s Certificate of Incorporation if the amendment, alteration, or repeal materially and adversely affects the powers, preferences, or special rights of the Series E Preferred Stock, (ii) any amendment, alteration, or repeal of this Certificate of Designations, or (iii) the creation or issuance of any Senior Stock; provided, however, that any increase in the authorized preferred stock of the Company or the creation and issuance of any Junior Stock or Parity Stock shall not be deemed to affect materially and adversely such powers, preferences or special rights and any such increase or creation and issuance may be made without any such vote by the holders of the Series E Preferred Stock, except as otherwise required by law.

5.    Conversion Rights.

(a)    Optional Conversion of Series E Preferred Stock.    Subject to Sections 5(k) and 5(l) below, the holder of any shares of Series E Preferred Stock shall have the right, at such holder’s option, at any time or from time to time to convert any or all of such holder’s shares of Series E Preferred Stock into such number of fully paid and nonassessable shares of Common Stock (the “Conversion Shares”) as determined for each share of Series E Preferred Stock by dividing the Conversion Value (as defined in Section 5(d) below) by the Conversion Price (as defined in Section 5(d) below). The “Conversion Value” per share means, as of any date, the sum of (i) the Original Issue Price plus (ii) an amount which accrues from the Original Issue Date at a rate of Sixty Cents ($.60) per annum, computed on the basis of a 360-day year to the date of conversion (the “Accrual Amount”). Unless adjusted pursuant to the anti-dilution rights set forth in the following sentence, the “Conversion Price” shall be Three Dollars and Twenty-Five Cents ($3.25) per share (as adjusted for any stock splits, reorganizations, dividends, recapitalizations and the like). After September 30, 2003, in the event that ninety percent (90%) of the volume weighted average price of the Company’s Common Stock from the hours of 9:30 a.m. to 4:00 p.m. on the NASDAQ as reported by Bloomberg Financial using the AQR function (the “Market Price”) for the five (5) trading days immediately preceding the date of conversion for which there are reported transactions in the Common Stock (the “Discount Market Price”) is less

3

than Three Dollars and Twenty-Five Cents ($3.25) per share (as adjusted for any stock splits, reorganizations, dividends, recapitalizations and the like), the Conversion Price shall be reduced to the Discount Market Price; provided, however, that in no event shall the Conversion Price be less than Two Dollars ($2.00) per share (as adjusted for any stock splits, reorganizations, dividends, recapitalizations and the like). Notwithstanding anything to the contrary set forth above, each such conversion at the option of the holder pursuant to this Section 5(a) shall cover at least the total number of shares of Series E Preferred Stock then held by such holder or a number of shares of Series E Preferred Stock having an aggregate Conversion Value of at least $50,000. The Conversion Shares and the Conversion Price are subject to certain adjustments as set forth herein, and the terms Conversion Shares and Conversion Price as used herein shall as of any time be deemed to include all such adjustments to be given effect as of such time in accordance with the terms hereof.

Upon the exercise of the option of the holder of any shares of Series E Preferred Stock to convert Series E Preferred Stock into Common Stock, the holder of such shares of Series E Preferred Stock to be converted shall surrender the certificates representing the shares of Series E Preferred Stock to be converted in the manner provided in Section 5(d) below. Immediately following such conversion, the rights of the holders of the Series E Preferred Stock that has been converted shall cease and the persons entitled to receive the Common Stock upon the conversion of Series E Preferred Stock shall be treated for all purposes as having become the owners of such Common Stock.

(b)    Automatic Conversion.    Each remaining outstanding share of Series E Preferred Stock shall be automatically converted into shares of Common Stock on December 31, 2006 in accordance with the provisions of Section 5(a) hereof. Pursuant to this Section 5(b), on the Conversion Date (as defined in Section 5(d) below), all outstanding shares of Series E Preferred Stock shall be converted into that number of shares of Common Stock as determined in accordance with Section 5(a) hereof as if the conversion of such number of shares of Series E Preferred Stock were made by the holders thereof in accordance therewith without any further action on the part of such holders.

(c)    Conversion at Option of Company.    If for any ten (10) consecutive trading days the Market Price of the Company’s Common Stock is at least Nine Dollars and Fifty Cents ($9.50) per share (as adjusted for stock splits, reorganizations, dividends, recapitalizations and the like), then at any time within ten (10) business days after the end of such ten (10) trading day period, the Company shall have the right to require the conversion of all outstanding shares of Series E Preferred Stock into shares of Common Stock in accordance with the provisions of Section 5(a) hereof by giving written notice to each holder of Series E Preferred Stock at such holder’s registered address. Such notice shall state the Conversion Date calculated pursuant to Section 5(d) below, and shall inform holders that they may be required to divest beneficial ownership prior to the Conversion Date to avoid the restriction on conversion contained in Section 5(l) below. In the event that the Company elects to convert shares of Series E Preferred Stock to Common Stock pursuant to the terms of this Section 5(c) prior to March 31, 2005, the Company shall only be able to require such conversion if a registration statement filed with the SEC registering the resale of the Conversion Shares is then effective. For purposes of this Section 5(c), if on any date there shall be no reported closing bid price, the “Market Price” on

4

such date shall be the closing bid price on the date next preceding such date on which a closing bid price for such security has been reported. Pursuant to this Section 5(c), on the Conversion Date (as defined in Section 5(d) below), all outstanding shares of Series E Preferred Stock shall be converted into that number of shares of Common Stock as determined in accordance with Section 5(a) hereof as if the conversion of such number of shares of Series E Preferred Stock were made by the holders thereof in accordance therewith without any further action on the part of such holders; provided, however, that if the Conversion Date is prior to the date which is one year after the Original Issue Date, the Conversion Value shall be equal to the higher of (i) Ten Dollars and Sixty Cents ($10.60) (as adjusted for any stock splits, reorganizations, dividends, recapitalizations and the like), or (ii) the Conversion Value determined in accordance with Section 5(a) hereof and further provided that conversion shall be limited as set forth in Section 5(l) below.

(d)    Delivery of Stock Certificates.    The holder of any shares of Series E Preferred Stock may exercise the optional conversion right pursuant to Section 5(a) above by delivering to the Company or its duly authorized transfer agent during regular business hours at the office of the Company the certificate or certificates for the shares of Series E Preferred Stock to be converted, duly endorsed or assigned either in blank or to the Company (if required by it), accompanied by written notice (the “Conversion Notice”) stating that such holder elects to convert such shares of Series E Preferred Stock and shall provide a certificate to the Company or its duly authorized transfer agent as to the date of such conversion. Upon the occurrence of an automatic conversion pursuant to Section 5(b) above or conversion at the option of the Company pursuant to Section 5(c) above, the Company shall deliver notice to each holder of Series E Preferred Stock and the holder of any shares of Series E Preferred Stock shall deliver to the Company at the office of the Company the certificate or certificates for all shares of Series E Preferred Stock then held by such holder, duly endorsed or assigned either in blank or to the Company (if requested by it). Conversion shall be deemed to have been effected (1) in the case of an optional conversion pursuant to Section 5(a), on the date when the aforesaid delivery of the Conversion Notice is made if such day is a business day and otherwise on the business day following the date of the aforesaid delivery, (2) in the case of an automatic conversion pursuant to Section 5(b) on December 31, 2006, or (3) in the case of conversion at the option of the Company pursuant to Section 5(c), ten (10) trading days after the date of the notice, and in each case such date is referred to herein as the “Conversion Date.” As promptly as practicable thereafter, the Company, through its transfer agent, if any, shall issue and deliver to or upon the written order of such holder, to the place designated by such holder, a certificate or certificates for the number of full shares of Common Stock to which such holder is entitled and a check or cash in respect of any fractional interest in a share of Common Stock, as provided below; provided, however, that in the case of a conversion in connection with liquidation, no such certificates need be issued. The person in whose name the certificate or certificates for Common Stock are to be issued shall be deemed to have become the stockholder of record in respect of such Common Stock on the applicable Conversion Date unless the transfer books of the Company are closed on that date, in which event such holder shall be deemed to have become the stockholder of record in respect of such Common Stock on the next succeeding date on which the transfer books are open, but the Conversion Value and the Conversion Price shall be that in effect on the Conversion Date. Upon conversion of only a portion of the number of shares

5

covered by a stock certificate representing shares of Series E Preferred Stock surrendered for conversion, the Company shall issue and deliver to or upon the written order of the holder of the stock certificate so surrendered for conversion, at the expense of the Company, a new stock certificate covering the number of shares of Series E Preferred Stock representing the unconverted portion of the certificate so surrendered. Any transfer taxes applicable to the above described transactions shall be paid by such transferee. The Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of Common Stock or the reissuance of the Preferred Stock in a name other than that in which the shares of Series E Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the person requesting such issuance has paid to the Company the amount of any such tax or has established to the satisfaction of the Company that such tax has been paid.

(e)    No Fractional Shares of Common Stock.    No fractional shares of Common Stock shall be issued upon conversion of shares of Series E Preferred Stock and in lieu thereof, the Company shall pay to the holder of such fractional share interest cash in respect of such fractional interest in an amount equal to the Market Price on the Conversion Date multiplied by such fractional interest. The holders of fractional interests shall not be entitled to any rights as stockholders of the Company in respect of such fractional interests. In determining the number of shares of Common Stock and the payment, if any, in lieu of fractional shares that a holder of Series E Preferred Stock shall receive, the total number of shares of Series E Preferred Stock surrendered for conversion by such holder shall be aggregated.

(f)    Changes in Common Stock.    If any capital reorganization or reclassification of the capital stock of the Company, or consolidation or merger of the Company with another corporation, or the sale, transfer or other disposition of all or substantially all of its assets to another corporation for cash or stock of such other corporation, shall be effected, then, as a condition of such reorganization, reclassification, consolidation, merger, sale, transfer or other disposition, lawful and adequate provision shall be made whereby each holder of Series E Preferred Stock shall thereafter have the right to purchase and receive upon the basis and upon the terms and conditions herein specified and in lieu of the shares of the Common Stock of the Company immediately theretofore issuable upon conversion of the Series E Preferred Stock, such shares of stock, securities or properties as may be issuable or payable with respect to or in exchange for a number of outstanding shares of such Common Stock equal to the number of shares of such Common Stock immediately theretofore issuable upon conversion of the Series E Preferred Stock had such reorganization, reclassification, consolidation, merger, sale, transfer or other disposition not taken place, and in any such case appropriate provisions shall be made with respect to the rights and interests of each holder of Series E Preferred Stock to the end that the provisions hereof (including without limitation provisions for adjustment of the Conversion Price) shall thereafter be applicable, as nearly equivalent as may be practicable in relation to any shares of stock, securities or properties thereafter deliverable upon the exercise thereof. The Company shall not effect any such consolidation, merger, sale, transfer or other disposition, unless prior to or simultaneously with the consummation thereof the successor corporation (if other than the Company) resulting from such consolidation or merger or the corporation purchasing or otherwise acquiring such properties shall assume, by written instrument executed and mailed or delivered to the holders of Series E Preferred Stock at the last address of such

6

holders appearing on the books of the Company, the obligation to deliver to such holders such shares of stock, securities or properties as, in accordance with the foregoing provisions, such holders may be entitled to acquire. The above provisions of this subparagraph shall similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales, transfers, or other dispositions.

(g)    Stock to be Reserved.    The Company will at all times reserve and keep available out of its authorized Common Stock, solely for the purpose of issue upon the conversion of Series E Preferred Stock as herein provided, such number of shares of Common Stock as shall then be issuable upon the conversion of all outstanding Series E Preferred Stock. The Company covenants that all shares of Common Stock which shall be so issuable shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, free from preemptive or similar rights on the part of the holders of any shares of capital stock or securities of the Company, and free from all liens and charges with respect to the issue thereof; and without limiting the generality of the foregoing, the Company covenants that it will from time to time take all such action as may be requisite to assure that the par value, if any, per share of the Common Stock is at all times equal to or less than the then effective Conversion Price. The Company will take all such action as may be necessary to assure that such shares of Common Stock may be so issued without violation by the Company of any applicable law or regulation or agreement, or of any requirements of any domestic securities exchange upon which the Common Stock may be listed. Without limiting the foregoing, the Company will take all such action as may be necessary to assure that, upon conversion of any of the Series E Preferred Stock, an amount equal to the lesser of (i) the par value of each share of Common Stock outstanding immediately prior to such conversion, or (ii) the Conversion Price shall be credited to the Company’s stated capital account for each share of Common Stock issued upon such conversion, and that, if clause (i) above is applicable, the balance of the Conversion Price of Series E Preferred Stock converted shall be credited to the Company’s capital surplus account.

(h)    Closing of Books.    The Company will at no time close its transfer books against the transfer of any Series E Preferred Stock or of any shares of Common Stock issued or issuable upon the conversion of any Series E Preferred Stock in any manner which interferes with the timely conversion of such Series E Preferred Stock.

(i)    Taxes.    The Company shall pay all documentary, stamp or other transactional taxes attributable to the issuance or delivery of shares of capital stock of the Company upon conversion of any shares of Series E Preferred Stock. The Company shall not, however, be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of Common Stock or the reissuance of the Series E Preferred Stock in a name other than that in which the shares of Series E Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the person requesting such issuance has paid to the Company the amount of any such tax or has established to the satisfaction of the Company that such tax has been paid.

(j)    Exclusion of Other Rights.    Except as may otherwise be required by law, the shares of Series E Preferred Stock shall not have any voting powers, preferences and relative,

7

participating, optional or other special rights, other than those specifically set forth in this Certificate of Designations and in the Certificate of Incorporation.

(k)    Limitation on Issuance of Conversion Shares.

(i)    Notwithstanding any adjustment of the Conversion Price made under this Section 5, and except as provided below, the Company shall not be obligated to issue upon conversion of the Series E Preferred Stock, in the aggregate, more than that number of shares of Common Stock, which when added to the maximum number of shares of Common Stock issuable upon exercise of all warrants issued by the Company in connection with the sale of the Series E Preferred Stock, is equal to 19.99% of the number of shares of Common Stock of the Company outstanding on the Original Issue Date (such amount to be proportionately and equitably adjusted from time to time in the event of stock splits, stock dividends, combinations, reverse stock splits, reclassifications, capital reorganization and similar events relating to the Common Stock) (the “Maximum Share Amount”) if the issuance of shares of Common Stock in excess of the Maximum Share Amount (such number of excess shares referred to in the aggregate as the “Excess Shares”) would constitute a breach or violation of the rules or regulations of the Nasdaq Stock Market or any other principal securities exchange or market upon which the Common Stock is or becomes listed or traded (the “Exchange Rules”).

(ii)    To the extent the Company will be required, or it appears likely to the Board of Directors of the Company that it will be required, to issue any Excess Shares as a result of an adjustment to the Conversion Price, the Company shall promptly use its best efforts to seek stockholder approval. The number of shares comprising the Maximum Share Amount (and if applicable, any Excess Shares to be issued) shall be allocated among the holders of the shares of Series E Preferred Stock pro rata based on the total number of shares of Series E Preferred Stock then outstanding.

(iii)    The limitations in this Section 5(k) will apply so long as shares of Series E Preferred Stock remain outstanding and will not be terminated due to any change in the status of the Company’s listing on the Nasdaq Stock Market.

(l)    Additional Restrictions on Conversion or Transfer.

(i)    In no event shall a holder of shares of Series E Preferred Stock of the Company have the right to convert or be required to convert the shares of Series E Preferred Stock into shares of Common Stock to the extent that such right to effect such conversion would result in the holder or any of its affiliates together beneficially owning more than 9.99% of the outstanding shares of Common Stock (the “Threshold”). For purposes of this subsection, beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and Regulation 13D-G thereunder. The provisions of this subsection may be waived by a holder of shares of Series E Preferred Stock as to itself (and solely as to itself) upon not less than 65 days prior written notice to the Company, and the provisions of this subsection shall continue to apply until such 65^th day (or later, if stated in the notice of waiver). In the case of conversion at the option of the Company pursuant to Section 5(c), any shares of Series E Preferred Stock not converted into Common Stock on the Conversion

8

Date (as defined in Section 5(d)) due to the limits imposed by the Threshold shall be redeemed by the Company on such Conversion Date for an amount equal to the Conversion Value of such shares on such Conversion Date, which amount shall be due and payable, without interest, on the one year anniversary of such Conversion Date.

(ii)    Notwithstanding anything to the contrary contained in this Section 5(l), this Section 5(l) shall be of no further force or effect after October 31, 2006, the date that is 61 days prior to the automatic conversion date of December 31, 2006 as described in Section 5(b).

6.    No Redemption.    Except as set forth in Section 5(l) above, the Series E Preferred Stock shall not be redeemable by the Company.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

9

IN WITNESS WHEREOF, this Certificate of Designation of Series E Preferred Stock has been subscribed this 28^th day of February 2003, by the undersigned who affirms that the statements made herein are true and correct.

American Technology Corporation
By:	/s/    Elwood G. Norris
	Name: Elwood G. Norris
	Title: Chairman of the Board

EX-4.3

Exhibit 4.3

No. W-E            

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

WARRANT TO PURCHASE              SHARES

OF COMMON STOCK

OF AMERICAN TECHNOLOGY CORPORATION

(Void after December 31, 2007)

This certifies that                      or its assigns (the “Holder”), for value received, is entitled to purchase from AMERICAN TECHNOLOGY CORPORATION, a Delaware corporation (the “Company”), having a place of business at 13114 Evening Creek Drive South, San Diego, California 92128, a maximum of              fully paid and nonassessable shares of the Company’s Common Stock (“Common Stock”) for cash at a price of Three Dollars and Twenty-Five Cents ($3.25) per share, as may be adjusted as provided herein (the “Stock Purchase Price”), at any time or from time to time up to and including 5:00 p.m. (Pacific time) on December 31, 2007 (the “Expiration Date”), upon surrender to the Company at its principal office (or at such other location as the Company may advise the Holder in writing) of this Warrant properly endorsed with the Form of Subscription attached hereto duly filled in and signed and, if applicable, upon payment in cash or by check of the aggregate Stock Purchase Price for the number of shares for which this Warrant is being exercised determined in accordance with the provisions hereof. The Stock Purchase Price and the number of shares purchasable hereunder are subject to adjustment as provided in Section 3 of this Warrant.

This warrant to purchase Common Stock (this “Warrant”) is one of a series of warrants issued pursuant to the Series E Preferred Stock and Warrant Purchase Agreement dated as of             , 2003 (the “Purchase Agreement”), which warrants are collectively referred to herein as the “Warrants.”

This Warrant is subject to the following terms and conditions:

1.    EXERCISE; ISSUANCE OF CERTIFICATES; PAYMENT FOR SHARES.

1.1    General.     This Warrant is exercisable at the option of the holder of record hereof, at any time or from time to time, up to the Expiration Date for all or any part of the shares of Common Stock (but not for a fraction of a share) which may be purchased hereunder. The Company agrees that the shares of Common Stock purchased under this Warrant shall be and are deemed to be issued to the Holder hereof as the record owner of such shares as of the close of business on the date on which this Warrant shall have been surrendered, properly endorsed, the completed, executed Form of Subscription delivered and payment made for such shares. Certificates for the shares of Common Stock so purchased, together with any other securities or

1

property to which the Holder hereof is entitled upon such exercise, shall be delivered to the Holder hereof by the Company at the Company’s expense within five (5) business days after the rights represented by this Warrant have been so exercised. In case of a purchase of less than all the shares which may be purchased under this Warrant, the Company shall cancel this Warrant and execute and deliver a new Warrant or Warrants of like tenor for the balance of the shares purchasable under the Warrant surrendered upon such purchase to the Holder hereof within five (5) business days. Each stock certificate so delivered shall be in such denominations of Common Stock as may be requested by the Holder hereof and shall be registered in the name of such Holder. Notwithstanding anything to the contrary set forth above, each exercise of the Warrant shall cover at least the lesser of (i) 10,000 shares of Common Stock (as adjusted for stock splits, stock dividends, combinations and the like), or (ii) the total number of shares of Common Stock then subject to the Warrant.

1.2    Net Issue Exercise.

(a)    Section 1.2(b) shall not apply and shall have no force or effect if, in accordance with the terms of the Purchase Agreement, the shares of Common Stock issuable upon exercise of this Warrant have been registered for resale under the Securities Act of 1933, as amended, on a registration statement on Form S-3, or another appropriate form.

(b)    Notwithstanding any provisions herein to the contrary (other than Section 1.2(a)), if the fair market value of one share of the Company’s Common Stock is greater than the Stock Purchase Price (at the date of calculation as set forth below), in lieu of exercising this Warrant for cash, the Holder may elect to receive shares equal to the value (as determined below) of this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with the properly endorsed Form of Subscription and notice of such election in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the following formula:

X =	Y (A-B)
	A

Where X = the number of shares of Common Stock to be issued to the Holder

Y =     the number of shares of Common Stock purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being canceled (at the date of such calculation)

A =    the fair market value of one share of the Company’s Common Stock (at the date of such calculation)

B =    Stock Purchase Price (as adjusted to the date of such calculation)

2

For purposes of the above calculation, fair market value of one share of Common Stock shall be the volume weighted average price of the Company’s Common Stock from the hours of 9:30 a.m. to 4:00 p.m. on the NASDAQ as reported by Bloomberg Financial using the AQR function for the five (5) trading days immediately preceding the date of exercise for which there are reported transactions in the Common Stock.

2.    SHARES TO BE FULLY PAID; RESERVATION OF SHARES.    The Company covenants and agrees that all shares of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will, upon issuance, be duly authorized, validly issued, fully paid and nonassessable and free from all preemptive rights of any stockholder and free of all taxes, liens and charges with respect to the issue thereof. The Company further covenants and agrees that, during the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized and reserved, for the purpose of issue or transfer upon exercise of the subscription rights evidenced by this Warrant, a sufficient number of shares of authorized but unissued Common Stock, or other securities and property, when and as required to provide for the exercise of the rights represented by this Warrant. The Company will take all such action as may be necessary to assure that such shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of any domestic securities exchange upon which the Common Stock may be listed; provided, however, that the Company shall not be required to effect a registration under Federal or State securities laws with respect to such exercise other than as provided pursuant to the Purchase Agreement. The Company will not take any action which would result in any adjustment of the Stock Purchase Price (as set forth in Section 3 hereof) if the total number of shares of Common Stock issuable after such action upon exercise of all outstanding warrants, together with all shares of Common Stock then outstanding and all shares of Common Stock then issuable upon exercise of all options and upon the conversion of all convertible securities then outstanding, would exceed the total number of shares of Common Stock then authorized by the Company’s Certificate of Incorporation.

3.    ADJUSTMENT OF STOCK PURCHASE PRICE AND NUMBER OF SHARES.    The Stock Purchase Price and the number of shares purchasable upon the exercise of this Warrant shall be subject to adjustment from time to time upon the occurrence of certain events described in this Section 3. Upon each adjustment of the Stock Purchase Price, the Holder of this Warrant shall thereafter be entitled to purchase, at the Stock Purchase Price resulting from such adjustment, the number of shares obtained by multiplying the Stock Purchase Price in effect immediately prior to such adjustment by the number of shares purchasable pursuant hereto immediately prior to such adjustment, and dividing the product thereof by the Stock Purchase Price resulting from such adjustment.

3.1    Subdivision or Combination of Stock.    In case the Company shall at any time subdivide its outstanding shares of Common Stock into a greater number of shares, the Stock Purchase Price in effect immediately prior to such subdivision shall be proportionately reduced, and conversely, in case the outstanding shares of Common Stock of the Company shall be combined into a smaller number of shares, the Stock Purchase Price in effect immediately prior to such combination shall be proportionately increased.

3

3.2    Dividends in Common Stock, Other Stock, Property, Reclassification.    If at any time or from time to time the Holders of Common Stock (or any shares of stock or other securities at the time receivable upon the exercise of this Warrant) shall have received or become entitled to receive, without payment therefor,

(a)    Common Stock or any shares of stock or other securities which are at any time directly or indirectly convertible into or exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend or other distribution,

(b)    any cash paid or payable otherwise than as a cash dividend, or

(c)    Common Stock or additional stock or other securities or property (including cash) by way of spinoff, split-up, reclassification, combination of shares or similar corporate rearrangement, (other than shares of Common Stock issued as a stock split or adjustments in respect of which shall be covered by the terms of Section 3.1 above),

then and in each such case, the Holder hereof shall, upon the exercise of this Warrant, be entitled to receive, in addition to the number of shares of Common Stock receivable thereupon, and without payment of any additional consideration therefor, the amount of stock and other securities and property (including cash in the cases referred to in clause (b) above and this clause (c)) which such Holder would hold on the date of such exercise had he been the holder of record of such Common Stock as of the date on which holders of Common Stock received or became entitled to receive such shares or all other additional stock and other securities and property.

3.3    Reorganization, Reclassification, Consolidation, Merger or Sale.    If any recapitalization, reclassification or reorganization of the capital stock of the Company, or any consolidation or merger of the Company with another corporation, or the sale of all or substantially all of its assets or other transaction shall be effected in such a way that holders of Common Stock shall be entitled to receive stock, securities, or other assets or property (an “Organic Change”), then, as a condition of such Organic Change, lawful and adequate provisions shall be made by the Company whereby the Holder hereof shall thereafter have the right to purchase and receive (in lieu of the shares of the Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented hereby) such shares of stock, securities or other assets or property as may be issued or payable with respect to or in exchange for a number of outstanding shares of such Common Stock equal to the number of shares of such stock immediately theretofore purchasable and receivable upon the exercise of the rights represented hereby; provided, however, that in the event the value of the stock, securities or other assets or property (determined in good faith by the Board of Directors of the Company) issuable or payable with respect to one share of the Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented hereby is in excess of the Stock Purchase Price hereof effective at the time of a merger and securities received in such reorganization, if any, are publicly traded, then this Warrant shall expire unless exercised prior to or simultaneous with such Organic Change. In the event of any Organic Change, appropriate provision shall be made by the Company with respect to the rights and interests of the Holder of this Warrant to the end that the provisions hereof (including, without limitation,

4

provisions for adjustments of the Stock Purchase Price and of the number of shares purchasable and receivable upon the exercise of this Warrant) shall thereafter be applicable, in relation to any shares of stock, securities or assets thereafter deliverable upon the exercise hereof. The Company will not effect any such consolidation, merger or sale unless, prior to the consummation thereof, the successor corporation (if other than the Company) resulting from such consolidation or the corporation purchasing such assets shall assume by written instrument reasonably satisfactory in form and substance to the Holders of a majority of the warrants to purchase Common Stock then outstanding, executed and mailed or delivered to the registered Holder hereof at the last address of such Holder appearing on the books of the Company, the obligation to deliver to such Holder such shares of stock, securities or assets as, in accordance with the foregoing provisions, such Holder may be entitled to purchase.

3.4    Certain Events.    If any change in the outstanding Common Stock of the Company or any other event occurs as to which the foregoing provisions of this Section 3 are not strictly applicable or if strictly applicable would not fairly protect the purchase rights of the Holder of the Warrant in accordance with such provisions, then the Board of Directors of the Company shall make an adjustment in the number and class of shares available under the Warrant, the Stock Purchase Price or the application of such provisions, so as to protect such purchase rights as aforesaid. The adjustment shall be such as will give the Holder of the Warrant upon exercise for the same aggregate Stock Purchase Price the total number, class and kind of shares as he would have owned had the Warrant been exercised prior to the event and had he continued to hold such shares until after the event requiring adjustment.

3.5    Notices of Change.

(a)    Within 10 business days after any adjustment in the number or class of the shares subject to this Warrant and of the Stock Purchase Price, the Company shall give written notice thereof to the Holder, setting forth in reasonable detail and certifying the calculation of such adjustment.

(b)    The Company shall give written notice to the Holder at least 15 business days prior to the date on which the Company closes its books or takes a record for determining rights to receive any dividends or distributions.

(c)  The Company shall also give written notice to the Holder at least 15 business days prior to the date on which an Organic Change shall take place.

4.    ISSUE TAX.    The issuance of certificates for shares of Common Stock upon the exercise of the Warrant shall be made without charge to the Holder of the Warrant for any issue tax (other than any applicable income taxes) in respect thereof; provided, however, that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate in a name other than that of the then Holder of the Warrant being exercised.

5.    CLOSING OF BOOKS.    The Company will at no time close its transfer books against the transfer of any warrant or of any shares of Common Stock issued or issuable

5

upon the exercise of any warrant in any manner which interferes with the timely exercise of this Warrant.

6.    NO VOTING OR DIVIDEND RIGHTS; LIMITATION OF LIABILITY.    Other than as set forth herein, nothing contained in this Warrant shall be construed as conferring upon the Holder hereof the right to vote or to consent or to receive notice as a shareholder of the Company or any other matters or any rights whatsoever as a shareholder of the Company. No dividends or interest shall be payable or accrued in respect of this Warrant or the interest represented hereby or the shares purchasable hereunder until, and only to the extent that, this Warrant shall have been exercised. No provisions hereof, in the absence of affirmative action by any holder, and no mere enumeration herein of the rights or privileges of the holder hereof, shall give rise to any liability of such Holder for the Stock Purchase Price or as a shareholder of the Company, whether such liability is asserted by the Company or by its creditors.

7.    WARRANTS TRANSFERABLE.    Subject to compliance with applicable federal and state securities laws, this Warrant and all rights hereunder are transferable, in whole or in part, without charge to the holder hereof (except for transfer taxes), upon surrender of this Warrant properly endorsed. Each taker and holder of this Warrant, by taking or holding the same, consents and agrees that this Warrant, when endorsed in blank, shall be deemed negotiable, and that the holder hereof, when this Warrant shall have been so endorsed, may be treated by the Company, at the Company’s option, and all other persons dealing with this Warrant as the absolute owner hereof for any purpose and as the person entitled to exercise the rights represented by this Warrant, or to the transfer hereof on the books of the Company any notice to the contrary notwithstanding; but until such transfer on such books, the Company may treat the registered owner hereof as the owner for all purposes.

8.    RIGHTS AND OBLIGATIONS SURVIVE EXERCISE OF WARRANT.    The rights and obligations of the Company, of the holder of this Warrant and of the holder of shares of Common Stock issued upon exercise of this Warrant, shall survive the exercise of this Warrant.

9.    MODIFICATION AND WAIVER.    This Warrant and any provision hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement of the same is sought; provided, however, that any term of this Warrant may be amended with the written consent of the Company and the holders of Warrants representing a majority in interest of the shares of Common Stock then issuable upon exercise of the Warrants issued pursuant to the Purchase Agreement, and any amendment so effected shall be binding upon each holder of such Warrants.

10.    NOTICES.    Any notice, request or other document required or permitted to be given or delivered to the holder hereof or the Company shall be delivered or shall be sent by certified mail, postage prepaid, to each such holder at its address as shown on the books of the Company or to the Company at the address indicated therefor in the first paragraph of this Warrant or such other address as either may from time to time provide to the other.

6

11.    BINDING EFFECT ON SUCCESSORS.    This Warrant shall be binding upon any corporation succeeding the Company by merger, consolidation or acquisition of all or substantially all of the Company’s assets. All of the obligations of the Company relating to the Common Stock issuable upon the exercise of this Warrant shall survive the exercise and termination of this Warrant. All of the covenants and agreements of the Company shall inure to the benefit of the successors and assigns of the holder hereof.

12.    DESCRIPTIVE HEADINGS AND GOVERNING LAW.    The description headings of the several sections and paragraphs of this Warrant are inserted for convenience only and do not constitute a part of this Warrant. This Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the State of California.

13.    LOST WARRANTS.    The Company represents and warrants to the Holder hereof that upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation of this Warrant and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to the Company, or in the case of any such mutilation upon surrender and cancellation of such Warrant, the Company, at its expense, will make and deliver a new Warrant, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant.

14.    FRACTIONAL SHARE.    No fractional shares shall be issued upon exercise of this Warrant. The Company shall, in lieu of issuing any fractional share, pay the holder entitled to such fraction a sum in cash equal to such fraction multiplied by the then effective Stock Purchase Price.

15.    SPECIFIC PERFORMANCE.    The parties hereto hereby declare that it is impossible to measure in money the damages which will accrue to a party hereto or to their heirs, personal representatives, or assigns by reason of a failure to perform any of the obligations under this Warrant and agree that the terms of this Warrant shall be specifically enforceable. If any party hereto or his heirs, personal representatives, or assigns institutes any action or proceeding to specifically enforce the provisions hereof, any person against whom such action or proceeding is brought hereby waives the claim or defense therein that such party or such personal representative has an adequate remedy at law, and such person shall not offer in any such action or proceeding the claim or defense that such remedy at law exists.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

7

IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its officers, thereunto duly authorized this              day of             , 2003.

AMERICAN TECHNOLOGY CORPORATION, a Delaware corporation
By:
	Name:
	Title:

8

Exhibit A

SUBSCRIPTION FORM

Date:             ,         

American Technology Corporation

13114 Evening Creek Drive South

San Diego, California 92128

Attn: President

Ladies and Gentlemen:

The undersigned hereby elects to exercise the warrant issued to it by American Technology Corporation (the “Company”) and dated                          , 2003, Warrant No. W-D             (the “Warrant”) and to purchase thereunder              shares of the Common Stock of the Company (the “Shares”) at a purchase price of Three Dollars and Twenty-Five Cents ($3.25) per Share for an aggregate purchase price of              Dollars ($            ) (the “Purchase Price”).

Pursuant to the terms of the Warrant the undersigned has (check one that applies):

¨ Delivered the aggregate Purchase Price herewith in full in cash or by certified check or wire transfer; or

¨ Elected to Net Issue Exercise as described in Section 1.2 of the Warrant.

Very truly yours,

Signature

Name:                                                                                            

Title:                                                                                              

EX-4.4

Exhibit 4.6

AMERICAN TECHNOLOGY CORPORATION

AMENDMENT TO 8% SENIOR SECURED PROMISSORY NOTE

This Amendment to 8% Senior Secured Promissory Note (the “Amendment”) is made as of February 26, 2003, among AMERICAN TECHNOLOGY CORPORATION (the “Company”) and the holders of 8% Senior Secured Promissory Notes (the “Notes”) listed on Exhibit A attached hereto (“Holders”, and individually, a “Holder”).

WHEREAS, the Notes may be amended, waived or modified upon the written consent of the Company and the holders of at least a majority of the face amount of all then outstanding Notes; and

WHEREAS, the Company and the holders of at least a majority of the face amount of all the outstanding Notes desire to amend the Notes.

The Company and Holders therefore agree as follows:

1.    Voluntary Conversion.    Notwithstanding anything to the contrary contained in the Notes, any Holder may request to convert all or any portion of the principal balance of its Note (“Voluntary Conversion”) into Equity Securities (as defined in Section 6.2 of the Notes). Upon acceptance of such request by the Company in its sole discretion, such request shall be deemed an optional redemption by the Company pursuant to Section 6.1 of the Note, except that the second sentence of Section 6.1 shall not apply. The price of the redemption for the portion of principal to be converted shall be calculated pursuant to Section 6.3.1 of the Notes, using the closing date for the purchase of the Equity Securities as the Redemption Date. Such redemption price shall be applied to the purchase price for the Equity Securities; provided however, that the Company may, in its sole discretion, pay all or a portion of the accrued but unpaid interest on the Redemption Principal and the Early Retirement Premium (each as defined in Section 6.3.1) in cash to the converting Holder instead of applying such amounts to the purchase price for the Equity Securities (notwithstanding the second sentence of Section 6.1).

2.    Mandatory Redemption.    Section 6.2 of the Notes is amended to clarify that amounts applied to the purchase price for Equity Securities by virtue of Voluntary Conversions are not to be deemed gross proceeds received by the Company from sale of Equity Securities for purposes of determining when a Qualified Financing has occurred.

3.    Due Date.    The due date for the Notes is extended from December 31, 2003 to December 31, 2004, by replacing the date “December 31, 2003” with “December 31, 2004” in each place it appears in the Notes.

4.    Confirmation of Notes.    All other terms and provisions of the Notes not amended remain in full force and effect.

5.    No Waiver.    Except as specifically provided in this Amendment, the holders of the Notes have no obligation, nor have such holders made any commitment or representation, to any other amendment or modification of the Notes.

6.    No Novation.    This Amendment does not constitute a novation or a renewal of the Notes, but rather a modification of the Notes.

7.    General.    This Amendment is governed by and construed under the laws of the State of California, excluding that body of law relating to conflicts of law. This Amendment, the Notes and the related Security Agreement represent the entire agreement between the parties and neither party shall be bound by any prior discussions, proposals or oral agreements.

8.    Waiver and Amendment.    Any provision of the Amendment may be amended, waived or modified upon the written consent of the Company and the holders of at least a majority of the face amount of all then outstanding Notes.

9.    Counterparts.    This Amendment may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one document.

COMPANY:

AMERICAN TECHNOLOGY CORPORATION,

a Delaware corporation

By: /s/ Elwood G. Norris

Name: Elwood G. Norris

Title: Chairman of the Board

HOLDERS:

By:                                                                                                           

Name:                                                                                                     

Title:                                                                                                       

Address:                                                                                                

2